NRAS and neoplasm: The circulating NRAS mutations split the metabolic groups, and the IDH1 mutation was only found in Patient 3, however, it cannot be ruled out that a more detailed genomic analysis of the tumour itself could have revealed additional mutations which correlated with the metabolic changes observed.